Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9195 |
High Similarity |
NPD7411 |
Suspended |
0.9178 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.9091 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.9091 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.9048 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.9028 |
High Similarity |
NPD1549 |
Phase 2 |
0.902 |
High Similarity |
NPD7075 |
Discontinued |
0.9013 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8947 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8882 |
High Similarity |
NPD6801 |
Discontinued |
0.8874 |
High Similarity |
NPD4380 |
Phase 2 |
0.8824 |
High Similarity |
NPD7819 |
Suspended |
0.8824 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8759 |
High Similarity |
NPD2796 |
Approved |
0.869 |
High Similarity |
NPD1510 |
Phase 2 |
0.8679 |
High Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8654 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.86 |
High Similarity |
NPD6799 |
Approved |
0.859 |
High Similarity |
NPD7768 |
Phase 2 |
0.8581 |
High Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8542 |
High Similarity |
NPD1240 |
Approved |
0.8523 |
High Similarity |
NPD3750 |
Approved |
0.8519 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8516 |
High Similarity |
NPD1934 |
Approved |
0.8483 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.8483 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.8431 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8425 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8418 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8403 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8389 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8387 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8375 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8301 |
Intermediate Similarity |
NPD5401 |
Approved |
0.8291 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8255 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.8239 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8235 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8228 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8221 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8221 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8221 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8212 |
Intermediate Similarity |
NPD1243 |
Approved |
0.8199 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8194 |
Intermediate Similarity |
NPD920 |
Approved |
0.8188 |
Intermediate Similarity |
NPD3748 |
Approved |
0.8188 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.8188 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.8182 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8182 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8182 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8182 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8176 |
Intermediate Similarity |
NPD6651 |
Approved |
0.817 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.8151 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.8133 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8133 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8133 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8129 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8095 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8092 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8084 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8084 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.8072 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.8072 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8065 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.8063 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8061 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8039 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.8036 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8036 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8027 |
Intermediate Similarity |
NPD3268 |
Approved |
0.8027 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8012 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8012 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7988 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7988 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7988 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7987 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7931 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7931 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7922 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7922 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7891 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7891 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7853 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7843 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7841 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7841 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7834 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7805 |
Intermediate Similarity |
NPD919 |
Approved |
0.7778 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7778 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7778 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7765 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7764 |
Intermediate Similarity |
NPD5889 |
Approved |
0.7764 |
Intermediate Similarity |
NPD5890 |
Approved |
0.775 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.775 |
Intermediate Similarity |
NPD3226 |
Approved |
0.774 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7724 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7712 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7702 |
Intermediate Similarity |
NPD6585 |
Discontinued |
0.7687 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7687 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7665 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7665 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7655 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.764 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7635 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7627 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7622 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7613 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7561 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.755 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7529 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7529 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7516 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7515 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7514 |
Intermediate Similarity |
NPD4287 |
Approved |
0.75 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD9545 |
Approved |
0.75 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7484 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7473 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7471 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7468 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7456 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7451 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7438 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7436 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7436 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7436 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7436 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7434 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7421 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7407 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7405 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7403 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7403 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7396 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7389 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7389 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7389 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7389 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7389 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7368 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7361 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7349 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7346 |
Intermediate Similarity |
NPD5049 |
Phase 3 |
0.7346 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7338 |
Intermediate Similarity |
NPD943 |
Approved |
0.732 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7312 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7308 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7303 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7303 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7299 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7296 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7294 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.729 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7285 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7283 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7283 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7279 |
Intermediate Similarity |
NPD17 |
Approved |
0.7273 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.726 |
Intermediate Similarity |
NPD1894 |
Discontinued |
0.7251 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7249 |
Intermediate Similarity |
NPD7585 |
Approved |
0.7247 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7226 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7226 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7226 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7222 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7219 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7219 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7215 |
Intermediate Similarity |
NPD4477 |
Approved |
0.7215 |
Intermediate Similarity |
NPD4476 |
Approved |
0.7209 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7209 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7208 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7208 |
Intermediate Similarity |
NPD411 |
Approved |
0.7205 |
Intermediate Similarity |
NPD2354 |
Approved |
0.72 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7196 |
Intermediate Similarity |
NPD7583 |
Approved |
0.7186 |
Intermediate Similarity |
NPD7577 |
Discontinued |
0.7186 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7186 |
Intermediate Similarity |
NPD37 |
Approved |
0.7184 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7179 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7176 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.716 |
Intermediate Similarity |
NPD4966 |
Approved |
0.716 |
Intermediate Similarity |
NPD4965 |
Approved |
0.716
|
Intermediate Similarity |
NPD4967 |
Phase 2 |